As China Turns To Innovation, Quintiles Goes Local To Woo Chinese Customers
This article was originally published in The Pink Sheet Daily
Executive Summary
Unlike Quintile’s current offices in Beijing and Shanghai, newly launched Kun Tuo will focus solely on Chinese biopharma customers, offering them custom-tailored solutions at a competitive price point.
You may also be interested in...
China's Leading CROs Go On Shopping Spree To Become One-Stop Vendors
China's leading contract research organizations, Wuxi PharmaTech and ShangPharma, in a race to win over Big Pharma with integrated service platforms, announced separate deals Oct. 24 to expand into new strategic areas
From Biologics To Corporate Venture, China's Leading CRO Continues To Evolve
In an effort to boost its biological capabilities and continue its march into additional integrated services, China's leading contract research organization WuXi PharmaTech has acquired Abgent Inc., a provider of biological research agent products and services